{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T20:11:49Z","timestamp":1775074309762,"version":"3.50.1"},"posted":{"date-parts":[[2024,5,15]]},"group-title":"Infectious Diseases (except HIV\/AIDS)","reference-count":53,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The risk of cardiovascular outcomes in the post-acute phase of SARS-CoV-2 infection has been quantified among adults and children. This paper aimed to assess a multitude of cardiac signs, symptoms, and conditions, as well as focused on patients with and without congenital heart defects (CHDs), to provide a more comprehensive assessment of the post-acute cardiovascular outcomes among children and adolescents after COVID-19.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This retrospective cohort study used data from the RECOVER consortium comprising 19 US children\u2019s hospitals and health institutions between March 2020 and September 2023. Every participant had at least a six-month follow-up after cohort entry. Absolute risks of incident post-acute COVID-19 sequelae were reported. Relative risks (RRs) were calculated by contrasting COVID-19-positive with COVID-19-negative groups using a Poisson regression model, adjusting for demographic, clinical, and healthcare utilization factors through propensity scoring stratification.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 1,213,322 individuals under 21 years old (mean[SD] age, 7.75[6.11] years; 623,806 male [51.4%]) were included. The absolute rate of any post-acute cardiovascular outcome in this study was 2.32% in COVID-19 positive and 1.38% in negative groups. Patients with CHD post-SARS-CoV-2 infection showed increased risks of any cardiovascular outcome (RR, 1.63; 95% confidence interval (CI), 1.47-1.80), including increased risks of 11 of 18 post-acute sequelae in hypertension, arrhythmias (atrial fibrillation and ventricular arrhythmias), myocarditis, other cardiac disorders (heart failure, cardiomyopathy, and cardiac arrest), thrombotic disorders (thrombophlebitis and thromboembolism), and cardiovascular-related symptoms (chest pain and palpitations). Those without CHDs also experienced heightened cardiovascular risks after SARS-CoV-2 infection (RR, 1.63; 95% CI, 1.57-1.69), covering 14 of 18 conditions in hypertension, arrhythmias (ventricular arrhythmias and premature atrial or ventricular contractions), inflammatory heart disease (pericarditis and myocarditis), other cardiac disorders (heart failure, cardiomyopathy, cardiac arrest, and cardiogenic shock), thrombotic disorders (pulmonary embolism and thromboembolism), and cardiovascular-related symptoms (chest pain, palpitations, and syncope).<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Both children with and without CHDs showed increased risks for a variety of cardiovascular outcomes after SARS-CoV-2 infection, underscoring the need for targeted monitoring and management in the post-acute phase.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Clinical Perspective section<\/jats:title>\n                  <jats:sec>\n                    <jats:title>What is new?<\/jats:title>\n                    <jats:list list-type=\"bullet\">\n                      <jats:list-item>\n                        <jats:p>We investigated the risks of 18 post-acute COVID-19 cardiovascular outcomes in the pediatric population without Multisystem Inflammatory Syndrome in Children (MIS-C) in over 1 million patients, stratified by congenital heart defects (CHD) status.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>We extended the follow-up period beyond previous pediatric studies, ensuring every participant had at least a six-month follow-up after cohort entry.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>We included a comprehensive cross-section of the US pediatric population across various healthcare settings including primary, specialty, and emergency care, as well as testing and inpatient facilities.<\/jats:p>\n                      <\/jats:list-item>\n                    <\/jats:list>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>What are the clinical implications?<\/jats:title>\n                    <jats:list list-type=\"bullet\">\n                      <jats:list-item>\n                        <jats:p>Within the post-acute phase, children and adolescents previously infected with SARS-CoV-2 are at statistically significant increased risk of incident cardiovascular outcomes, including hypertension, ventricular arrhythmias, myocarditis, heart failure, cardiomyopathy, cardiac arrest, thromboembolism, chest pain, and palpitations. These findings are consistent among patients with and without CHDs.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>Awareness of the heightened risk of cardiovascular disorders after COVID-19 can lead to a timely referral, investigations, and management of these conditions in children and adolescents.<\/jats:p>\n                      <\/jats:list-item>\n                    <\/jats:list>\n                  <\/jats:sec>\n                <\/jats:sec>","DOI":"10.1101\/2024.05.14.24307380","type":"posted-content","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T23:00:10Z","timestamp":1715814010000},"source":"Crossref","is-referenced-by-count":5,"title":["Post-Acute Cardiovascular Outcomes of COVID-19 in Children and Adolescents: An EHR Cohort Study from the RECOVER Project"],"prefix":"10.64898","author":[{"given":"Bingyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6738-397X","authenticated-orcid":false,"given":"Deepika","family":"Thacker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dazheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqing","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1843-1955","authenticated-orcid":false,"given":"Elizabeth","family":"Chrischilles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitri A.","family":"Christakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soledad","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3778-5927","authenticated-orcid":false,"given":"Vidu","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abu S. M.","family":"Mosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion R.","family":"Sills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6414-4172","authenticated-orcid":false,"given":"Bradley W.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1252-068X","authenticated-orcid":false,"given":"Christopher B.","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0835-0788","authenticated-orcid":false,"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2024052000200809000_2024.05.14.24307380v1.1","doi-asserted-by":"crossref","unstructured":"Toepfner N , Brinkmann F , Augustin S , Stojanov S , Behrends U . Long COVID in pediatrics\u2014epidemiology, diagnosis, and management. Eur J Pediatr. Published online 2024.","DOI":"10.1007\/s00431-023-05360-y"},{"key":"2024052000200809000_2024.05.14.24307380v1.2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03553-9"},{"issue":"10","key":"2024052000200809000_2024.05.14.24307380v1.3","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/jamapediatrics.2022.2800","article-title":"Clinical features and burden of postacute sequelae of SARS-CoV-2 infection in children and adolescents","volume":"176","year":"2022","journal-title":"JAMA Pediatr"},{"issue":"3","key":"2024052000200809000_2024.05.14.24307380v1.4","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41591-022-01689-3","article-title":"Long-term cardiovascular outcomes of COVID-19","volume":"28","year":"2022","journal-title":"Nat Med"},{"key":"2024052000200809000_2024.05.14.24307380v1.5","doi-asserted-by":"crossref","unstructured":"Ayoubkhani D , Khunti K , Nafilyan V , et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. bmj. 2021;372.","DOI":"10.1136\/bmj.n693"},{"key":"2024052000200809000_2024.05.14.24307380v1.6","doi-asserted-by":"crossref","unstructured":"Daugherty SE , Guo Y , Heath K , et al. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. Bmj. 2021;373.","DOI":"10.1101\/2021.03.12.21253448"},{"key":"2024052000200809000_2024.05.14.24307380v1.7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.12603"},{"issue":"10270","key":"2024052000200809000_2024.05.14.24307380v1.8","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0140-6736(20)32656-8","article-title":"6-month consequences of COVID-19 in patients discharged from hospital: a cohort study","volume":"397","year":"2021","journal-title":"The Lancet"},{"key":"2024052000200809000_2024.05.14.24307380v1.9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac031"},{"key":"2024052000200809000_2024.05.14.24307380v1.10","doi-asserted-by":"crossref","unstructured":"Wang W , Wang CY , Wang SI , Wei JCC . Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: a retrospective cohort study from the TriNetX US collaborative networks. EClinicalMedicine. 2022;53.","DOI":"10.1016\/j.eclinm.2022.101619"},{"issue":"1","key":"2024052000200809000_2024.05.14.24307380v1.11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/cid\/ciad469","article-title":"Long-term Cardiovascular, Cerebrovascular, and Other Thrombotic Complications in COVID-19 Survivors: A Retrospective Cohort Study","volume":"78","year":"2024","journal-title":"Clinical Infectious Diseases"},{"key":"2024052000200809000_2024.05.14.24307380v1.12","doi-asserted-by":"crossref","unstructured":"Rao S , Gross RS , Mohandas S , et al. Postacute Sequelae of SARS-CoV-2 in Children. Pediatrics. Published online 2024:e2023062570.","DOI":"10.1542\/peds.2023-062570"},{"issue":"14","key":"2024052000200809000_2024.05.14.24307380v1.13","first-page":"517","article-title":"Cardiac complications after SARS-CoV-2 infection and mRNA COVID-19 vaccination\u2014PCORnet","volume":"71","year":"2022","journal-title":"United States, january 2021\u2013January 2022. Morbidity and Mortality Weekly Report"},{"key":"2024052000200809000_2024.05.14.24307380v1.14","doi-asserted-by":"crossref","unstructured":"Abi Nassif T , Fakhri G , Younis NK , et al. Cardiac manifestations in COVID-19 patients: a focus on the pediatric population. Canadian Journal of Infectious Diseases and Medical Microbiology. 2021;2021.","DOI":"10.1155\/2021\/5518979"},{"issue":"2","key":"2024052000200809000_2024.05.14.24307380v1.15","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00246-022-03020-w","article-title":"Long-term cardiovascular outcomes of multisystem inflammatory syndrome in children associated with COVID-19 using an institution based algorithm","volume":"44","year":"2023","journal-title":"Pediatr Cardiol"},{"key":"2024052000200809000_2024.05.14.24307380v1.16","unstructured":"Wu Q , Tong J , Zhang B , et al. Real-World Effectiveness of BNT162b2 Against Infection and Severe Diseases in Children and Adolescents. Ann Intern Med. Published online 2024."},{"key":"2024052000200809000_2024.05.14.24307380v1.17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.047549"},{"key":"2024052000200809000_2024.05.14.24307380v1.18","first-page":"15","article-title":"AHA\/ACC key data elements and definitions for cardiovascular and noncardiovascular complications of COVID-19: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Data Standards","volume":"2022","year":"2022","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2024052000200809000_2024.05.14.24307380v1.19","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2010.166"},{"key":"2024052000200809000_2024.05.14.24307380v1.20","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00472.x"},{"key":"2024052000200809000_2024.05.14.24307380v1.21","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-021-00709-9"},{"issue":"1","key":"2024052000200809000_2024.05.14.24307380v1.22","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cjca.2023.06.001","article-title":"Kawasaki Disease in the Time of COVID-19 and MIS-C: The International Kawasaki Disease Registry","volume":"40","year":"2024","journal-title":"Canadian Journal of Cardiology"},{"issue":"1-2","key":"2024052000200809000_2024.05.14.24307380v1.23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2298\/SARH1402113P","article-title":"Renal hypertension and cardiovascular disorder in children with chronic kidney disease","volume":"142","year":"2014","journal-title":"Srp Arh Celok Lek"},{"key":"2024052000200809000_2024.05.14.24307380v1.24","first-page":"559-569","volume":"Vol 38","year":"2018","journal-title":"Cardiovascular disease in children and adolescents with chronic kidney disease. In: Seminars in Nephrology"},{"issue":"3","key":"2024052000200809000_2024.05.14.24307380v1.25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.46376\/IJMR\/1.3.2020.97-102","article-title":"Multi system inflammatory syndrome in children and adolescents temporally related to COVID-19","volume":"1","year":"2020","journal-title":"GFNPSS-Int J Multidiscip Res"},{"key":"2024052000200809000_2024.05.14.24307380v1.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.08.056"},{"key":"2024052000200809000_2024.05.14.24307380v1.27","unstructured":"Centers for Disease Control and Prevention. COVID Data Tracker. Atlanta, GA: U.S. Department of Health and Human Services, CDC. Published December 15, 2023. https:\/\/covid.cdc.gov\/covid-data-tracker"},{"key":"2024052000200809000_2024.05.14.24307380v1.28","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(19)32317-7"},{"issue":"5","key":"2024052000200809000_2024.05.14.24307380v1.29","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.acap.2018.02.010","article-title":"Development and validation of the Pediatric Medical Complexity Algorithm (PMCA) version 3.0","volume":"18","year":"2018","journal-title":"Acad Pediatr"},{"issue":"1","key":"2024052000200809000_2024.05.14.24307380v1.30","doi-asserted-by":"crossref","first-page":"e2021053418","DOI":"10.1542\/peds.2021-053418","article-title":"Risk factors for severe COVID-19 in children","volume":"149","year":"2022","journal-title":"Pediatrics"},{"key":"2024052000200809000_2024.05.14.24307380v1.31","doi-asserted-by":"crossref","unstructured":"Walker AM , Patrick AR , Lauer MS , et al. A tool for assessing the feasibility of comparative effectiveness research. Comparative effectiveness research. Published online 2013:11\u201320.","DOI":"10.2147\/CER.S40357"},{"key":"2024052000200809000_2024.05.14.24307380v1.32","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3697"},{"issue":"5","key":"2024052000200809000_2024.05.14.24307380v1.33","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/aje\/kwaa267","article-title":"Defining, quantifying, and interpreting \u201cnoncollapsibility\u201d in epidemiologic studies of measures of \u201ceffect.\u201d","volume":"190","year":"2021","journal-title":"Am J Epidemiol"},{"key":"2024052000200809000_2024.05.14.24307380v1.34","doi-asserted-by":"publisher","DOI":"10.1214\/ss\/1009211805"},{"issue":"4","key":"2024052000200809000_2024.05.14.24307380v1.35","doi-asserted-by":"crossref","first-page":"e2021055765","DOI":"10.1542\/peds.2021-055765","article-title":"Severity of acute COVID-19 in children< 18 years old March 2020 to December 2021","volume":"149","year":"2022","journal-title":"Pediatrics"},{"key":"2024052000200809000_2024.05.14.24307380v1.36","unstructured":"GISAID, via CoVariants.org \u2013 Last updated 26 February 2024 \u2013 processed by Our World in Data. https:\/\/ourworldindata.org\/grapher\/covid-variants-area?time=earliest..2023-03-06&country=~USA"},{"key":"2024052000200809000_2024.05.14.24307380v1.37","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1708282114"},{"key":"2024052000200809000_2024.05.14.24307380v1.38","doi-asserted-by":"publisher","DOI":"10.1002\/sim.5925"},{"key":"2024052000200809000_2024.05.14.24307380v1.39","doi-asserted-by":"crossref","unstructured":"Daugherty SE , Guo Y , Heath K , et al. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. bmj. 2021;373.","DOI":"10.1101\/2021.03.12.21253448"},{"key":"2024052000200809000_2024.05.14.24307380v1.40","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.201686"},{"issue":"35","key":"2024052000200809000_2024.05.14.24307380v1.41","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.15585\/mmwr.mm7035e5","article-title":"Association between COVID-19 and myocarditis using hospital-based administrative data\u2014United States, March 2020\u2013January 2021","volume":"70","year":"2021","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"2024052000200809000_2024.05.14.24307380v1.42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2110475"},{"issue":"11","key":"2024052000200809000_2024.05.14.24307380v1.43","first-page":"e14470","article-title":"Myocarditis associated with Covid-19 disease: a systematic review of published case reports and case series","volume":"75","year":"2021","journal-title":"Int J Clin Pract"},{"issue":"9","key":"2024052000200809000_2024.05.14.24307380v1.44","doi-asserted-by":"crossref","first-page":"e497","DOI":"10.1093\/cid\/ciaa169","article-title":"Comparing propensity score methods versus traditional regression analysis for the evaluation of observational data: a case study evaluating the treatment of gram-negative bloodstream infections","volume":"71","year":"2020","journal-title":"Clinical Infectious Diseases"},{"issue":"4","key":"2024052000200809000_2024.05.14.24307380v1.45","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/19417381211039746","article-title":"Return to activity after SARS-CoV-2 infection: cardiac clearance for children and adolescents","volume":"14","year":"2022","journal-title":"Sports Health"},{"issue":"9","key":"2024052000200809000_2024.05.14.24307380v1.46","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1001\/jamacardio.2021.2065","article-title":"Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection: results from the big ten COVID-19 cardiac registry","volume":"6","year":"2021","journal-title":"JAMA Cardiol"},{"key":"2024052000200809000_2024.05.14.24307380v1.47","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00846-2"},{"issue":"2","key":"2024052000200809000_2024.05.14.24307380v1.48","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/pds.4680","article-title":"Inflation of type I error rates due to differential misclassification in EHR-derived outcomes: empirical illustration using breast cancer recurrence","volume":"28","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2024052000200809000_2024.05.14.24307380v1.49","first-page":"1764","volume":"Vol 2016","author":"American Medical Informatics Association","year":"2016","journal-title":"An empirical study for impacts of measurement errors on EHR based association studies. In: AMIA Annual Symposium Proceedings"},{"issue":"4","key":"2024052000200809000_2024.05.14.24307380v1.50","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jamainternmed.2020.8193","article-title":"Variation in US Hospital Mortality Rates for Patients Admitted With COVID-19 During the First 6 Months of the Pandemic","volume":"181","year":"2021","journal-title":"JAMA Intern Med"},{"key":"2024052000200809000_2024.05.14.24307380v1.51","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.056583"},{"key":"2024052000200809000_2024.05.14.24307380v1.52","doi-asserted-by":"crossref","unstructured":"Kohli U , Desai L , Chowdhury D , et al. mRNA coronavirus disease 2019 vaccine-associated myopericarditis in adolescents: a survey study. J Pediatr. 2022;243:208\u2013213.","DOI":"10.1016\/j.jpeds.2021.12.025"},{"key":"2024052000200809000_2024.05.14.24307380v1.53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004245"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.05.14.24307380","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:00:49Z","timestamp":1768507249000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2024.05.14.24307380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,15]]},"references-count":53,"URL":"https:\/\/doi.org\/10.1101\/2024.05.14.24307380","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s41467-025-56284-0","asserted-by":"subject"}],"has-review":[{"id-type":"doi","id":"10.1162\/2e3983f5.0178aa07","asserted-by":"object"},{"id-type":"doi","id":"10.1162\/2e3983f5.946e10cc","asserted-by":"object"},{"id-type":"doi","id":"10.1162\/2e3983f5.9d76f930","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2024,5,15]]},"subtype":"preprint"}}